Lv21
170 积分 2024-08-13 加入
Use of Single-Arm Trials for US Food and Drug Administration Drug Approval in Oncology, 2002-2021
1个月前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
6个月前
已完结
皖公网安备34019202002308
